Dr. Hunter Lang Named 2025 Mentor of the Year Posthumously by Merck Animal Health and the American Association of Bovine Practitioners

The award honors his lifetime of service and impact on countless veterinary careers

RAHWAY, N.J., Sept. 15, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), and the American Association of Bovine Practitioners (AABP) today announced Hunter Lang, D.V.M., has been named the 2025 Mentor of the Year. The award was presented posthumously and accepted by his wife, Laura Lang, at the 2025 AABP Annual Conference, held Sept. 12-14 in Omaha, Neb.

          Lang, who passed away on Jan. 29, 2025, was a beloved figure in the bovine veterinary community. The posthumous award honors his lifetime of service, profound impact on countless veterinary careers and enduring legacy.

          Lang’s career spanned more than 40 years practicing veterinary medicine in the greater Sauk Prairie community. Before retiring, he owned the Sauk Prairie Veterinary Clinic in Prairie du Sac, Wis. He was also an adjunct faculty member at the University of Wisconsin, School of Veterinary Medicine. He served on the AABP Animal Welfare Committee, on the AABP Board of Directors for two terms (2013-2018), and as the AABP Delegate to the AVMA House of Delegates from 2021-2025.

           “Merck Animal Health is proud to honor those who have had a positive and lasting impact on our profession, like Dr. Lang,” said Dave Sjeklocha, D.V.M., technical services manager at Merck Animal Health and president of the AABP Board of Directors. “He embodied the spirit of mentorship—patience, knowledge, and a deep commitment to the growth of others. We are honored to recognize his lifetime of contributions with this award, and we extend our heartfelt condolences to his family.”

           “Hunter’s mentorship was transformative for so many in our profession. His compassion, commitment to our profession, and the genuine care he showed his clients and mentees set a standard we all aspire to,” said Fred Gingrich II, D.V.M., executive director of AABP. “Though we mourn his loss, his legacy will continue to inspire future generations of bovine veterinarians.”

          In honor of his legacy, Lang’s family has endowed the Hunter Lang Dairy Welfare Scholarship for third- or fourth-year veterinary students interested in dairy practice and animal welfare. The first $2,000 scholarship was awarded at this year’s conference.

          Merck Animal Health maintains long-standing partnerships with educational institutions and associations, like AABP, to ensure the industry’s future needs are addressed. The company annually provides more than $1.4 million in veterinary scholarships and millions of dollars in financial support and grants to universities, associations and foundations.

          Founded in 1965, AABP is an international association of more than 5,000 veterinarians and veterinary students who serve as leaders in cattle health, welfare and productivity. To learn more, visit aabp.org.

Hunter Lang, D.V.M., was honored posthumously by Merck Animal Health and the American Association of Bovine Practitioners as the 2025 Mentor of the Year during AABP’s Annual Conference in Omaha, Neb.

About Merck Animal Health

          At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of Merck. Through its commitment to The Science of Healthier Animals^®, Merck Animal Health offers veterinarians, farmers, producers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com and connect with us on LinkedIn, Facebook, X (formerly Twitter) and Instagram.

Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA

          This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

          Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

          The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2023, and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).